Wed, Sep 17, 2014, 5:38 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Eli Lilly and Company Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • eightironfrom160 eightironfrom160 Jan 5, 2001 9:15 AM Flag

    Zovant/price drop

    as a doc, perhaps you can shed some light
    here--if Zovant is pretty much the only choice out there
    and even if it saves "only" 20% of these pts,
    wouldn't docs be obligated to try it? will they be able to
    determine if they should or should not use it prior to
    administration? (like the data we know have on the clot-buster
    drugs) Seems like the lawyers, who unfortunately dictate
    'the standard of care' would have a field day with
    plans and hospitals that deny a pt this drug.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 8iron,
      Sorry for the delay. Yes, I do think
      that the docs would be obligated to consider the drug
      despite the cost; however, it would be an individual
      decision based on many factors, such as the primary dx,
      mental facilities, quality of life (whatever that is),
      families wishes, and paramount, the wishes of the patient,
      if he or she is capable of rendering a rational
      Probably not much of an answer. I spent 5-6 years working
      on hospital Ethics committees wrestling with such
      dilemmas...probably that contributed to my slightly early
      Yet I feel Zovant could be a significant advance,
      when used properly. (its use will probably be
      monitored by some hospital committee).

65.91+0.11(+0.17%)Sep 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.